Amylyx Pharmaceuticals EMEA
Presence
Amylyx Pharmaceuticals is one of the...
Amylyx Pharmaceuticals is a company listed under the stock ticker AMLX (US).
Amylyx Pharmaceuticals has a direct presence in 2 countries.
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Amylyx Pharmaceuticals EMEA
- Stéphanie Hoffmann-Gendebien, Managing Director
- Bert De Jong, Head and General Manager, Benelux
- Chiara Troncatti, Head, Commercial Operations
Popular executive movements at Amylyx Pharmaceuticals
- Bernhardt Zeiher has joined the company as Director (posted on March 14 2024).
- Margaret Olinger, Global Head of Commercial and Chief Commercial Officer, will leave the company on Dec. 31, 2023 (posted on December 8 2023).
- Camille Bedrosian has joined the company as Chief Medical Officer (posted on November 28 2023).
Create your alert
to follow the executive moves at Amylyx Pharmaceuticals EMEA.
Pharmaceuticals
Amylyx Pharmaceuticals has 1,859 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Amylyx Pharmaceuticals EMEA
Social media about Amylyx Pharmaceuticals EMEA
- Amylyx Pharmaceuticals EMEA on Wikipedia, Google News & Yahoo Finance
- Amylyx Pharmaceuticals EMEA on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Susanne Digel 
Call Amylyx Pharmaceuticals EMEA at +32 77...
